Medicine Questions
Report an Adverse Event
Investors
Contact
North America South America
Asia
Middle East Africa Australia
Europe

Newsroom

Gilead’s Path to Equitable Global COVID-19 Treatment Access

Gilead’s first-in-class antiviral was made available to more than 11 million patients globally– over 65% of whom live in low-and lower-middle-income countries.

Mike Boyd - October 04, 2022

Photo of Mike Boyd

Recent Story Posts

Photo of Mike Boyd
Community

Gilead’s Path to Equitable Global COVID-19 Treatment Access

Mike Boyd - October 04, 2022
Dr. Amelie Ramirez with the University of Texas Health in San Antonio, Texas and Mays Cancer Center
Community

Dr. Amelie Ramirez Seeks to End Disparities in Latino Cancer Care

Stories@Gilead - September 28, 2022
Chris Chatmon, Chief Executive Officer, Kingmakers of Oakland
Community

Kingmakers of Oakland Aims to Improve the Lives of Young Black Men

Stories@Gilead - September 20, 2022

Recent Press Releases

Explore More

View Upcoming Events

Company Statements

2021 Year in Review

 

For more information, contact us.

Phone:
1-800-GILEAD-5 (1-800-445-3235) 1-800-GILEAD-5 (1-800-445-3235)

Email:
public_affairs@gilead.com